KAITLYN COBLER: Open Payments
NPI 1073093027 · STUART, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 83 payments from 24 companies in 2025. Trend: 2023 $1,422 · 2024 $1,340 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $196 |
| ABBVIE INC. | 14 | $179 |
| Novo Nordisk Inc | 5 | $105 |
| GENZYME CORPORATION | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $84 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Lilly USA, LLC | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
Products named: CAPLYTA, NURTEC ODT, DUPIXENT, XIFAXAN, INGREZZA, HETLIOZ, MOUNJARO, VRAYLAR.
Industry payments across VA — which companies pay providers there.
